etomoxir has been researched along with phosphatidylcholines in 1 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) |
---|---|---|---|---|---|
260 | 8 | 93 | 32,204 | 443 | 5,593 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brglez, V; Lambeau, G; Payré, C; Petan, T; Pucer, A; Pungerčar, J | 1 |
1 other study(ies) available for etomoxir and phosphatidylcholines
Article | Year |
---|---|
Group X secreted phospholipase A(2) induces lipid droplet formation and prolongs breast cancer cell survival.
Topics: AMP-Activated Protein Kinases; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Culture Media, Serum-Free; Enzyme Activation; Epoxy Compounds; Female; Gene Expression Regulation, Neoplastic; Group X Phospholipases A2; Humans; Hydrolysis; Lipid Metabolism; Oleic Acids; Organelles; Oxidation-Reduction; Phosphatidylcholines; Proto-Oncogene Proteins c-akt | 2013 |